Syndecan-1 (CD138) expression in human non-Hodgkin's lymphomas

被引：5
|
作者：
Sutcliffe, M
Oscier, D
Wright, DH
机构：
[1] Royal Bournemouth Hosp, Dept Haematol, Bournemouth BH7 7DW, Dorset, England
[2] Royal Bournemouth Hosp, Dept Histopathol, Bournemouth BH7 7DW, Dorset, England
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2000年 / 110卷 / 01期
关键词：
syndecan-1(CD138); non-Hodgkin's lymphoma;
D O I：
10.1046/j.1365-2141.2000.02072-5.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：239 / 240
页数：2
相关论文
共 50 条
  • [31] Syndecan-1/CD138 expression in normal myeloid, acute lymphoblastic and myeloblastic leukemia cells
    Seftalioglu, A
    Karakus, S
    ACTA HISTOCHEMICA, 2003, 105 (03) : 213 - 221
  • [32] Syndecan-1 (CD138) as a Pathogenesis Factor and Therapeutic Target in Breast Cancer
    Sheta, Mona
    Goette, Martin
    CURRENT MEDICINAL CHEMISTRY, 2021, 28 (25) : 5066 - 5083
  • [33] Decreased expression of Syndecan-1 (CD138) in the endometrium of adenomyosis patients suggests a potential pathogenetic role
    Shaalan, Walid
    Ibrahim, Mohamed Gamal
    Plasger, Ariana
    Hassan, Nourhan
    Kiesel, Ludwig
    Schuering, Andreas N.
    Goette, Martin
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2025, 104 (01) : 77 - 85
  • [34] Syndecan-1 (CD138) expression is related to an aggressive phenotype and to poorer prognosis in breast carcinoma.
    Barbareschi, M
    Aldovini, D
    Maisonneuve, P
    Cangi, MG
    Pecciarini, L
    Mauri, FA
    Caffo, O
    Galligioni, E
    Dalla Palma, P
    Doglioni, C
    MODERN PATHOLOGY, 2001, 14 (01) : 21A - 21A
  • [35] Syndecan-1 (CD138) expression in acute myeloblastic leukemia cells - An immuno electron microscopic study
    Seftalioglu, A
    Karakus, S
    Dundar, S
    Can, B
    Erdemli, E
    Irmak, MK
    Oztas, E
    Korkmaz, C
    Yazar, F
    Cavusoglu, I
    ACTA ONCOLOGICA, 2003, 42 (01) : 71 - 74
  • [36] Syndecan-1 (CD138) immunoreactivity in bone marrow biopsies of multiple myeloma: Shed syndecan-1 accumulates in fibrotic regions
    Bayer-Garner, IB
    Sanderson, RD
    Dhodapkar, MV
    Owens, RB
    Wilson, CS
    MODERN PATHOLOGY, 2001, 14 (10) : 1052 - 1058
  • [37] Advances in the molecular functions of syndecan-1 (SDC1/CD138) in the pathogenesis of malignancies
    Gharbaran, Rajendra
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2015, 94 (01) : 1 - 17
  • [38] Soluble Syndecan-1 (CD138) - A Novel Biomarker in Patients With Inflammatory Bowel Disease
    Yablecovitch, Doron
    Stein, Assaf
    Naftali, Timna
    Gabay, Gila
    Laish, Ido
    Benjaminov, Fabiana
    Konikoff, Fred M.
    GASTROENTEROLOGY, 2013, 144 (05) : S423 - S423
  • [39] Syndecan-1 (CD138) Regulates Competition Between Antibody Secreting Cells for Survival
    Fooksman, David R.
    McCarron, Mark
    JOURNAL OF IMMUNOLOGY, 2018, 200 (01):
  • [40] Syndecan-1 (CD138) expression in multiple myeloma: Immunohistochemical and flow cytometric analysis in bone marrow specimens
    Bayer-Garner, IB
    Sanderson, RD
    Dhodapkar, MV
    Owens, RB
    Wilson, CS
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1999, 112 (04) : 563 - 564
12345